Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Experimental literature describes BPC-157 as a relatively stable short peptide compared with many endogenous regulatory peptides
Exact dosing depends on experimental design
serious risks include pancreatitis and gallbladder disease, and neither is licensed by the MHRA, so use outside clinical trials is not supported
It was withdrawn from the market in November 2007 due to excess renal failure, cardiac complications and mortality, although it was more effective than the other two substances in reducing bleeding risk and transfusion rates [13,31]
US$ 26.98
US$ 28.92
US$ 23.80
US$ 26.63
US$ 28.27
US$ 24.22
US$ 26.10
US$ 24.20
US$ 22.78
US$ 25.59
US$ 23.94
US$ 23.01
US$ 20.70
US$ 24.83
US$ 23.83
US$ 23.17
